BioCardia Reports 2020 Financial Results and Recent Business Highlights
SAN CARLOS, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for...
Month: March 2021
Tiziana Announces the FDA Has Allowed Treatment for a Secondary Progressive Multiple Sclerosis (SPMS) Patient for the Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS) (“Tiziana” or...
Turkish Ministry of Health Approves Increase in Patient Recruitment into the Phase II Trial for LSALT Peptide
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
Kiadis EGM adopts all resolutions related to the recommended public offer by Sanofi
This is a press release by Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by Sanofi Foreign Participations...
Tiziana Life Sciences plc: Accustem Update
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company...
Acerus Announces Expansion of NATESTO® Distribution Worldwide
Maylen Farma to Market Treatment in 20 Countries across Europe, Central Asia and the Middle EastTORONTO, March 30, 2021 (GLOBE...
Evaxion Biotech to Host Full-Year 2020 Corporate Update Conference Call & Webcast on April 6
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the...
Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis
CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing...
Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study
WILMETTE, Ill., March 30, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
ContraFect Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Exebacase Phase 3 DISRUPT study enrollment ongoing in patients with Staph aureus bloodstream infections; results from interim futility analysis anticipated...
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
Wambach joins a growing team assembled to increase awareness regarding the unmet medical need for a treatment for brain injuries...
International development strategy pursuit in Asia and in the United States
Press release Ecully, 29 March 2021 – 6 p.m. Continued international development Workshop in Thailand dedicated to Spineway implants and...
Ascendis Pharma A/S Announces Participation at the J.P. Morgan 10th Annual Napa Valley Biotech Forum
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative...
Silence Therapeutics Reports Full-year 2020 Results
Silence Therapeutics Reports Full-year 2020 ResultsAdvancing clinical programmes; On-track for three phase 1 data readouts in 2021 30 March 2021...
Immatics Announces Full Year 2020 Financial Results and Corporate Update
Phase 1a data update from clinical ACTengine® programs demonstrated first anti-tumor activity at early phases of dose escalation in heavily...
Longeveron Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
MIAMI, March 30, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
Augmedix Announces Successful Completion of Debt Refinancing
SAN FRANCISCO, March 30, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (“Augmedix”), a leading provider of remote medical documentation and live...
OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization
Tests designed to detect active COVID-19 infection with a simple, easy-to-use workflowBETHLEHEM, Pa., March 30, 2021 (GLOBE NEWSWIRE) -- OraSure...
Silo Wellness Hires Two Veterans of Lifestyle Marketing and Cannabis Industry to Promote Marley Line of Functional & Psychedelic Mushroom Brand
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (CSE: SILO), a wellness company in the psychedelics and functional...
VBL Therapeutics to Host Virtual R&D Day on April 6
TEL AVIV, Israel, March 30, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced that it will host a...